SavedAdd your journal

Journals / Medical Network Klinik Bilimler ve Doktor / 2003 / Cilt: 9 - Sayı: 6

Review of 161 patients with upper gastrointestinal system bleeding

Üst gastrointestinal sistem kanamalı 161 hastanın değerlendirilmesi

Zahide ŞİMŞEK
Timur HARZADIN
İ. Safa YILDIRIM
Pages
675–680
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients must be evaluated carefully especially with high age, aspirin and other NSAII drug used.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study we aimed to assess the risk factors that precipitated bleeding and mortality in upper GIS bleeding patients.
📊
Key Findings & Data:Symptoms of patients, number of repeated bleeding, intake of provoking medicines, other systemic diseases, endoscopie findings, mortality rate, blood transfusion requirements and the need for operation were recorded.
💡
Conclusion & Impact:Patients must be evaluated carefully especially with high age, aspirin and other NSAII drug used.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Geriyedönük çalışma · Gastrointestinal kanama · Ölüm oranı

Abstract

Objective: In this study we aimed to assess the risk factors that precipitated bleeding and mortality in upper GIS bleeding patients. Materials and Methods: One hundred sixty-one patients with upper gastrointestinal bleeding were evaluated retrospectively. Symptoms of patients, number of repeated bleeding, intake of provoking medicines, other systemic diseases, endoscopie findings, mortality rate, blood transfusion requirements and the need for operation were recorded. Result: Upper GIS bleeding was observed most commonly in men of 3-6 decades. 161 patients, 81.9% of whom were performed within the first 24 hours, were performed endoscopy. Duodenal ulcer was observed in 20.4% patient by endoscopy. 16.1% of patients have been taking aspirin and 13.6% nonsteroid antiinflamantory drug. Liver cirrhosis (18.6%), hypertension (14.2%) and diabetes mellitus (11.8%) were determined which are known to be the causing common diseases upper gastrointestinal bleebing. Four or more units of blood were transfused to 48 patients. The average blood transfusion requirement was 2.59i2.19 units. 16 patients were sent to surgery. 14 Patients were lost. Conclusion: Because of high mortality and morbidity the patients with upper GIS bleeding must be follow up in intensive care units. Patients must be evaluated carefully especially with high age, aspirin and other NSAII drug used.

Özet

Amaç: Bu çalışmada, üst gastrointestinal sistem (GİS) kanama tanısı ile izlenen hastalarda kanamayı kolaylaştıran ve mortaliteyi etkileyen faktörlerinin araştırılması amaçlandı. Gereç ve Yöntem: SSK Ankara Eğitim Hastanesi III.Dahiliye Kliniği'nde Şubat 1999-Kasım 2000 tarihleri.arasında üst GİS kanaması nedeniyle izlenmiş olan 161 hasta; başvuru şikayetleri, kanama sayısı, kanamayı kolaylaştıran ilaç kullanımı, eşlik eden sistemik hastalıklar, endoskopi bulguları, kan transfüzyonu, operasyon gereksinimi ve mortalité yönünden retrospektif olarak incelenmiştir. Bulgular: Üst GiS kanamaları en sık 30-60 yaşlarında ve erkeklerde görülmüştür. Hastaların %20'sine ilk 24 saat içinde olmak üzere %81.9'una üst GiS endoskopisi yapıldı. En sık rastlanan lezyon duedonum ülseriydi (%20.4). Hastaların %61'inde aspirin, %13.6'smda aspirin dışında nonsteroid antiinflamatuvar ilaç (NSAlİ) kullanım öyküsü mevcuttu. En sık eşlik eden sistemik hastalıklar; karaciğer sirozu (%18.6), hipertansiyon (%14.2), diabetes mellitus (%11.8) olarak saptandı. 48 hastaya 4 ünite ve üzerinde kan transfüzyonu yapılmıştı. Ortalama kan tranfüzyonu gereksinimi 2.59-2.19 üniteydi.16 hasta (%10) genel cerrahi kliniğine nakledildi.14 hasta (%8.6) takip sırasında kaybedildi. Sonuç: Üst GİS kanamalı hastalar, yüksek mortalité ve morbidité nedeni ile yoğun bakım ünitelerinde takip edilmelidir. Özellikle; ileri yaş, aspirin ve diğer NSAİİ kullanımı, eşlik eden sistemik hastalıkların varlığı yönünden dikkatle değerlendirilmelidir.

🔖

Cite This Article

ŞİMŞEK, Z., HARZADIN, T., YILDIRIM, İ. S. (2003). Review of 161 patients with upper gastrointestinal system bleeding. Medical Network Klinik Bilimler ve Doktor, Cilt: 9 - Sayı: 6, 675–680. https://ajindex.com/articles/278665

References (11)

  1. Larson G, Schmidt T, Gott J, Bond S, O'Connor CA, Richardson JD. Upper gastrointestinal bleeding: predictors of outcome. Surgery 1986; 100:765-70. Gönen Ö. Gastrointestinal kanamalar. In. İliçin G, Ünal S, Biberoğlu K, Akalın S, Süleymanlar G (ed): Temel iç hastalıkları. 1. basım. Ankara: Güneş kitapevi; 1996:1060-165.
  2. Richardson CT, Schiiller LR, Peterson WL, Thirlby RC, Feldman M. In. Wyngarden JB, Smith LH, Bennet JC (eds): Peptic ulcer. Cecil textbook of medicine. 19th ed. Philadelphia: WB Saunders CO; 1992:652-67.
  3. Sandel MH, Kolkman JJ, Kuipers.EJ. Nonvariceal upper gastrointestinal bleeding; differences in outcome for patients admitted to internal medicine and gastroenterological services. Am. J. Gastroenterol 2000; 95:2357-62.
  4. Laine L, Peterson WL. Bleeding peptic ulcer. New. Eng. J. Med. 1994; 331:717-27.
  5. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Incidence of and mortalty from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. Br: Med. J. 1995;311:222-6.
  6. Fried LS, Paul M. The problem of gastrointestinal bleeding. Gastroenterol Clin North Am.1993; 22:717-21.
  7. Laporte JR, Came X, Vidal X, Moreno V, Juan J. Upper gast­ rointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Catalan Countries Study on Upper Gastrointestinal Bleeding. Lancet 1991; 337:85-9.
  8. Al-Assi MT, Genta RM, Karttunen TJ, Graham DY. Ulcer site and complications: Relation to Helicobacter pylori infection and NSAID use. Endoscopy 1996; 28:229-33. Vreeburg EM, de Bruijne HW, Snel P, Bartelsman JW, Rauws EA, Tytgat GN. Previous use of non-steroidal anti-inflammatory drugs and anticoagulants: the influence on clinical outcome of bleeding gastroduodenal ulcers. Eur J Gastroenterol Hepatol 1997; 9:1-4.
  9. Rockall TA, Legon RF, Devin HB, Nortfield TC. Risk asses- ment after acute upper gastrointestinal haemorrhage. Gut 1996; 38:316-21.
  10. Rockall TA, Logam RF, Devlin HB, Nortfield TC. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal haemorhage. Lancet 1996; 347:1138-40. Skok P. Does endoscopic hemostasis affect the reduction of mortality in patients with hemorrhage from the digestive tract? Hepatology-Gastroenterology 1998; 45:23-7.
  11. Rollhauser C, Flerscher DE. Nonvariceal upper gastrointes­ tinal bleeding. Endoscopy 2002; 34:1